VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis

被引:212
作者
Matsumoto, T
Bohman, S
Dixelius, J
Berge, T
Dimberg, A
Magnusson, P
Wang, L
Wikner, C
Qi, JH
Wernstedt, C
Wu, J
Bruheim, S
Mugishima, H
Mukhopadhyay, D
Spurkland, A
Claesson-Welsh, L
机构
[1] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden
[2] Nihon Univ, Sch Med, Div Cell Regenerat & Transplantat, Adv Med Res Ctr,Itabashi Ku, Tokyo, Japan
[3] Univ Oslo, Dept Anat, Inst Basal Med Sci, Oslo, Norway
[4] Mayo Clin Fdn, Rochester, MN USA
[5] Cleveland Clin Fdn, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44195 USA
[6] Biomed Ctr, Ludwig Inst Canc Res, Uppsala Branch, Uppsala, Sweden
[7] Cummings Ctr, Beverly, MA USA
[8] Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway
关键词
actin cytoskeleton; TSAd; tumor angiogenesis; tyrosine phosphorylation site; VEGFR-2;
D O I
10.1038/sj.emboj.7600709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor receptor-2 (VEGFR-2) activation by VEGF-A is essential in vasculogenesis and angiogenesis. We have generated a pan-phosphorylation site map of VEGFR-2 and identified one major tyrosine phosphorylation site in the kinase insert (Y951), in addition to two major sites in the C-terminal tail (Y1175 and Y1214). In developing vessels, phosphorylation of Y1175 and Y1214 was detected in all VEGFR-2-expressing endothelial cells, whereas phosphorylation of Y951 was identified in a subset of vessels. Phosphorylated Y951 bound the T-cell-specific adapter (TSAd), which was expressed in tumor vessels. Mutation of Y951 to F and introduction of phosphorylated Y951 peptide or TSAd siRNA into endothelial cells blocked VEGF-A-induced actin stress fibers and migration, but not mitogenesis. Tumor vascularization and growth was reduced in TSAd-deficient mice, indicating a critical role of Y951-TSAd signaling in pathological angiogenesis.
引用
收藏
页码:2342 / 2353
页数:12
相关论文
共 27 条
[1]  
Boyer Stephen J., 2002, Current Topics in Medicinal Chemistry, V2, P973, DOI 10.2174/1568026023393273
[2]   Vascular endothelial growth factor and the nervous system [J].
Brockington, A ;
Lewis, C ;
Wharton, S ;
Shaw, PJ .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (05) :427-446
[3]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[4]  
Choi YB, 1999, J IMMUNOL, V163, P5242
[5]   Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites [J].
Dixelius, J ;
Mäkinen, T ;
Wirzenius, M ;
Karkkainen, MJ ;
Wernstedt, C ;
Alitalo, K ;
Claesson-Welsh, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :40973-40979
[6]   Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization [J].
Dougher, M ;
Terman, BI .
ONCOGENE, 1999, 18 (08) :1619-1627
[7]   BIOLOGICAL-ACTIVITY AND PHOSPHORYLATION SITES OF THE BACTERIALLY EXPRESSED CYTOSOLIC DOMAIN OF THE KDR VEGF-RECEPTOR [J].
DOUGHERVERMAZEN, M ;
HULMES, JD ;
BOHLEN, P ;
TERMAN, BI .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (01) :728-738
[8]   Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications [J].
Ferrara, N .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :10-14
[9]   Newest findings on the oldest oncogene;: how activated src does it [J].
Frame, MC .
JOURNAL OF CELL SCIENCE, 2004, 117 (07) :989-998
[10]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364